Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Protein A Resin Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The protein a resin market has experienced significant expansion over recent years. It is anticipated to expand from $1.78 billion in 2025 to $1.95 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. The growth observed historically can be ascribed to the rise of biopharmaceutical manufacturing, the broadening of antibody-based therapeutics, the growing application of affinity chromatography, increased investments in biologics r&d, and the availability of recombinant protein a technologies.
The protein a resin market is anticipated to experience substantial growth over the next few years, with projections indicating it will reach $2.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This expected expansion is driven by factors such as the increasing development of biologics pipelines, the rising adoption of continuous manufacturing, the growth in biosimilar production, a heightened focus on cost-efficient purification processes, and an increasing demand for high-throughput chromatography. Noteworthy trends during this period include the increased utilization of high-capacity protein a resins, the growing embrace of single-use chromatography systems, the rising demand for monoclonal antibody production, the expansion of continuous bioprocessing, and an enhanced emphasis on resin reusability.
Get A Free Sample Report With In-Depth Market Insights:
Protein A Resin Market Demand Drivers Opening New Revenue Streams
Higher investments in research and development by pharmaceutical firms are projected to drive expansion in the protein A resin market. R&D refers to the process of researching and developing new drugs, therapies, technologies, or services that can be used to improve the health of patients. In pharmaceutical development procedures, protein A resin serves as a chromatography medium in various chromatography assays. For instance, in February 2024, according to IQVIA, a US-based public company/contract research organization (CRO) and healthcare analytics provider, which reported in 2023, global funding of biopharmaceutical research and development increased to $72Bn, up from $61Bn in 2022. As a result, the increased R&D investments in pharmaceutical companies are propelling the growth of the protein A resin market.
Protein A Resin Market Segment Performance And Emerging Opportunities
The protein a resin market covered in this report is segmented –
1) By Type: Natural Protein A, Recombinant Protein A
2) By Matrix Type: Agarose-Based Protein A, Glass Or Silica-Based Protein A, Organic Polymer-Based Protein A
3) By Application: Antibody Purification, Immunoprecipitation
4) By End User: Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes
Subsegments:
1) By Natural Protein A: Affinity Chromatography Resins, Protein Purification Resins, IgG Binding Resins
2) By Recombinant Protein A: Full-Length Recombinant Protein A Resins, Engineered Protein A Domain Resins, Alkaline-Stable Recombinant Protein A Resins, High-Binding-Capacity Recombinant Protein A Resins, Low-Ligand-Leaching Recombinant Protein A Resins
Protein A Resin Market Trends Powering Strategic Industry Growth
Leading companies within the protein A resin market are prioritizing the advancement of dependable technological solutions, such as polymer technology, to enhance productivity and overcome particular difficulties in the purification of intricate biomolecules during biopharmaceutical production. Within protein A resin, polymer technology serves to optimize the performance and stability of these resins in chromatography processes for antibody purification, by augmenting binding capacity, chemical resistance, and operational lifespan. A notable illustration occurred in September 2024, when JSR Life Sciences, a US-based entity specializing in the development and production of diverse biomedical materials, unveiled Amsphere A+, its next-generation protein A chromatography resin. This product is crafted to elevate antibody drug purification, delivering superior binding capacity, enhanced stability, and greater efficiency when contrasted with its precursor, Amsphere A3. This novel resin is intended to accommodate the escalating intricacy of antibody drug manufacturing, especially concerning bispecific antibodies and antibody-drug conjugates. It achieves this through the incorporation of a proprietary protein ligand and cutting-edge polymer technology, thereby boosting overall production efficiency.
Protein A Resin Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the protein a resin market are Repligen Corporation, Tosoh Corporation, Sartorius AG, Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Kaneka Corporation, JSR Corporation, Mitsubishi Chemical Group, GenScript Biotech Corporation, Asahi Kasei Corporation, Toray Industries, Inc., YMC Co., Ltd., Chisso Corporation, Sekisui Chemical Co., Ltd., Daicel Corporation, Purolite Life Sciences, Jiangsu Tiance Biotech Co., Ltd., Suzhou Nanomicro Technology Co., Ltd., Beijing Sepax Technologies, Inc.
View The Full Protein A Resin Market Report:
Protein A Resin Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the Protein A Resin market in 2025. Europe is expected to be the fastest-growing region in the protein A resin market report during the forecast period. The regions covered in the protein a resin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
